Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Global Antihyperlipidemic Drugs Market Analysis
Hyperlipidaemia is a critical medical condition, arising due to abnormally high levels of cholesterol in the body. Around 24% of the cardiovascular diseases are attributable to high LDL cholesterol in the body. It occurs due to accumulation of atherosclerotic plaque resulting in insufficient blood flow to important body parts like brain, heart, and limbs. As a result, significant antihyperlipidemic drugs market growth can be anticipated in the coming years.
Statins are the most preferred treatment alternative for lowering LDL (bad) cholesterol and triglycerides while increasing HDL (good) cholesterol in the body. However, it also poses a risk of symptoms like headaches, dizziness, or digestive issues. Although the side effects are commonly treated with the help of combination medicines, there has been significant research to come up with improved and side-effect free statins. For instance, atorvastatin nanocrystals have been developed to combat the issue of its poor gastric solubility and low absolute bioavailability. This indicates that we can expect a significant growth in antihyperlipidemic drugs market value with rising research and development in the field.
Medical researchers are adopting new technologies to develop potent and affordable antihyperlipidemic drugs, with an aim to curb the threat of chronic cardiovascular diseases majorly associated with cholesterol levels. Bempedoic acid works on the mechanism of cholesterol synthesis inhibition. Other emerging drugs are Evinacumab (based on the use of monoclonal antibodies), Inclisiran and Volanesorsen (based on antisense oligonucleotides mechanism). Such developments in the pharmaceutical industry will be a key factor for high market demand in the future.
Antihyperlipidemic Drugs Market Report Snapshots
Antihyperlipidemic Drugs Market Size
Antihyperlipidemic Drugs Market Analysis
Antihyperlipidemic Drugs Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 12.91 billion in 2023, driven by the increasing prevalence of cardiac diseases, lipid disorders, and hyperlipidaemia cases globally.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, likely to reach a market value of USD 21.44 billion by 2032.
The emphasis on reducing the number of deaths associated with high cholesterol, along with new drug developments, drive the demand for these drugs.
High income countries like the United States, north-western Europe, Australia have seen a decrease in number of cardiac deaths. This can be attributed to the existence of a profound healthcare and pharmaceutical industry. However, the fastest growth can be expected in Asian region, owing to a high percentage of aging population and increased investments by the government to improve healthcare industry.
Antihyperlipidemic drugs include statins, PCSK9 inhibitors, bile acid sequestrants, cholesterol absorption inhibitors, fibric acid derivatives, and combination.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The distribution channels in the market are hospitals pharmacies, retail pharmacies, drug stores and E-commerce.
Key players involved in the market are Bristol-Myers Squibb Company, Merck & Co., AstraZeneca, Mylan N.V, Abbott, Aparito Ltd., Amgen Inc., Daiichi Sankyo Company, Pfizer Inc., and Dr. Reddy’s Laboratories Ltd.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124